These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37207298)

  • 41. In-silico screening of high production volume chemicals for mutagenicity using the MCASE QSAR expert system.
    Klopman G; Chakravarti SK; Harris N; Ivanov J; Saiakhov RD
    SAR QSAR Environ Res; 2003 Apr; 14(2):165-80. PubMed ID: 12747573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alarms about structural alerts.
    Alves V; Muratov E; Capuzzi S; Politi R; Low Y; Braga R; Zakharov AV; Sedykh A; Mokshyna E; Farag S; Andrade C; Kuz'min V; Fourches D; Tropsha A
    Green Chem; 2016 Aug; 18(16):4348-4360. PubMed ID: 28503093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automatic knowledge extraction from chemical structures: the case of mutagenicity prediction.
    Ferrari T; Cattaneo D; Gini G; Golbamaki Bakhtyari N; Manganaro A; Benfenati E
    SAR QSAR Environ Res; 2013; 24(5):365-83. PubMed ID: 23710765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A practice of expert review by read-across using QSAR Toolbox.
    Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
    Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A knowledge-based expert rule system for predicting mutagenicity (Ames test) of aromatic amines and azo compounds.
    Gadaleta D; Manganelli S; Manganaro A; Porta N; Benfenati E
    Toxicology; 2016 Aug; 370():20-30. PubMed ID: 27644887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integration of structure-activity relationship and artificial intelligence systems to improve in silico prediction of ames test mutagenicity.
    Mazzatorta P; Tran LA; Schilter B; Grigorov M
    J Chem Inf Model; 2007; 47(1):34-8. PubMed ID: 17238246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and prevalidation of a list of structure-activity relationship rules to be used in expert systems for prediction of the skin-sensitising properties of chemicals.
    Gerner I; Barratt MD; Zinke S; Schlegel K; Schlede E
    Altern Lab Anim; 2004 Nov; 32(5):487-509. PubMed ID: 15656773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimizing machine-learning models for mutagenicity prediction through better feature selection.
    Shinada NK; Koyama N; Ikemori M; Nishioka T; Hitaoka S; Hakura A; Asakura S; Matsuoka Y; Palaniappan SK
    Mutagenesis; 2022 Oct; 37(3-4):191-202. PubMed ID: 35554560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenic and carcinogenic structural alerts and their mechanisms of action.
    Plošnik A; Vračko M; Dolenc MS
    Arh Hig Rada Toksikol; 2016 Sep; 67(3):169-182. PubMed ID: 27749264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.
    Coppi A; Davies R; Wegesser T; Ishida K; Karmel J; Han J; Aiello F; Xie Y; Corbett MT; Parsons AT; Monticello TM; Minocherhomji S
    Regul Toxicol Pharmacol; 2022 Jun; 131():105162. PubMed ID: 35331777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting the mutagenic potential of chemicals in tobacco products using
    Goel R; Valerio LG
    Toxicol Mech Methods; 2020 Nov; 30(9):672-678. PubMed ID: 32752976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
    Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Data-based review of QSARs for predicting genotoxicity: the state of the art.
    Benigni R; Bossa C
    Mutagenesis; 2019 Mar; 34(1):17-23. PubMed ID: 30260416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
    Amberg A; Anger LT; Bercu J; Bower D; Cross KP; Custer L; Harvey JS; Hasselgren C; Honma M; Johnson C; Jolly R; Kenyon MO; Kruhlak NL; Leavitt P; Quigley DP; Miller S; Snodin D; Stavitskaya L; Teasdale A; Trejo-Martin A; White AT; Wichard J; Myatt GJ
    Mutagenesis; 2019 Mar; 34(1):67-82. PubMed ID: 30189015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology.
    Cariello NF; Wilson JD; Britt BH; Wedd DJ; Burlinson B; Gombar V
    Mutagenesis; 2002 Jul; 17(4):321-9. PubMed ID: 12110629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From Structural Alerts to Signature Fragment Alerts: A Case Study on Pyrrolizidine Alkaloids.
    Lo Piparo E; Christinat N; Badoud F
    Chem Res Toxicol; 2023 Feb; 36(2):213-229. PubMed ID: 36692496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of phototransformation products of thalidomide and mixture toxicity assessment: an experimental and quantitative structural activity relationships (QSAR) approach.
    Mahmoud WM; Toolaram AP; Menz J; Leder C; Schneider M; Kümmerer K
    Water Res; 2014 Feb; 49():11-22. PubMed ID: 24316178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Silico Methods for Carcinogenicity Assessment.
    Golbamaki A; Benfenati E; Roncaglioni A
    Methods Mol Biol; 2022; 2425():201-215. PubMed ID: 35188634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.